Australia's Perdaman Pharma Seeks To Build Formulation Plant In India
This article was originally published in PharmAsia News
Executive Summary
Perdaman Pharmaceuticals, an Australian manufacturer of branded generics, plans to build a $181 million formulation facility In India, home country of the company's owner, Vikas Rambal
Perdaman Pharmaceuticals, an Australian manufacturer of branded generics, plans to build a $181 million formulation facility In India, home country of the company's owner, Vikas Rambal. India FDA's commissioner in Gujarat said Perdaman is seeking acreage there for the facility. Perdaman said it expects to sign a memorandum of understanding for the deal soon. (Click here for more)
"Australia's Perdaman Mulls 1,000 Crore At Halol" - Times Of India (9/12/2012)